secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mosaic ImmunoEngineering Inc. (CPMV)
CIK:        0000836564
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001683168-22-001209
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mosaic ImmunoEngineering raises $342K via 8% convertible notes with board participation
--------------------------------------------------------------------------------

- Issued $342,632 principal of 8% convertible notes to 16 accredited investors; 5 board members invested $155,000 combined.
- Proceeds of $341,632 for general purposes; notes have no maturity, 8% simple interest, convertible in future equity financing.
- Conversion price: lesser of 80% of lowest per-share price in Qualified Financing (≥$5M) or $1.00; also convertible in smaller financings.
- Upon corporate transaction, holders may elect 1.5x principal plus interest or conversion at $1.00 per share.
- Amended May 2021 notes for certain purchasers: conversion price replaced with same formula (80% discount or $1.00).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/0001683168-22-001209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/mosiac_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-001209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer